FDA Finally Set To Approve Multiple Sclerosis Drug This March, Is There A Catch?
Hope for Multiple Sclerosis patients has once again been revived after it was recently announced that the cure to overcome the illness is soon to be launched. Putting emphasis to those inflicted with progressive types of MS who have not found a drug that has the ability of working to reduce flares, improve symptoms, or slow disease progression. As of the press time, it was found that nearly 2.3 million people worldwide are living with the disease.
FDA On Approving Multiple Sclerosis Drug This March
According to reports revealed by Health Line, after series of delays, the Food and Drug Administration is finally set to approve a certain drug that is believed to have the ability in curing the disease late March this year. Officials from Roche Pharmaceuticals, the developer of the said cure has also claimed that for the first time ever, people with primary progressive MS (PPMS) may benefit from what they consider to be a medical breakthrough. During the large scale phase III trial, the drug named as Ocrevus has reportedly shown to significantly slow the progression of physical disability in people with PPMS. However, despite the success of these trials, the production of Ocrevus or also known as ocrelizumab has been delayed.
Why Has It Been Delayed?
Meanwhile, as per Multiple Sclerosis News Today, due to manufacturing issues, the long-awaited approval of FDA has been pushed to late March 2017. Additionally, Genentech, a member of the Roche Group, has explained that the U.S. Food and Drug Administration (FDA) has decided to extend the Prescription Drug User Fee Act (PDUFA) due to the submission of additional data by Genentech regarding the commercial manufacturing process of Ocrevus, which required additional time for FDA review. Furthermore, Genentech clarifies that the reason was actually contrary to the speculations that the reason was about the efficacy or safety of Ocrevus.
The Future Of Multiple Sclerosis Is Here! $8.4-Million Funding Granted To Top Scientists To Work On MS Cure
As US top scientists gear up for their yet biggest research for Multiple Sclerosis, why is it called 'a once in a lifetime opportunity' study? Is this where the future of the auto immune disease lies? How essential is this research if it were to be successful? Here's what authorities have to say.
Overcoming Multiple Sclerosis: Your Ultimate Guide To Wellness After MS Attack
Exactly just what is Multiple Sclerosis? Considering the number of Multiple Sclerosis cases that continuously grows, how does one deal with overcoming the disease? Are there simple life hacks that could help in the recovery process, or we just have to rely purely on the drugs available over the counter? Here are the facts.
Serum MicroRNAs Shed Light For Multiple Sclerosis Patients: Could This Be The Cure?
Considering the number of proposed and alleged cure to the ever rising cases of Multiple Sclerosis, how can the so-called Serum MicroRNAs change the status quo? Is this the cure that millions of people have been waiting for? Have we found the answer to Multiple Sclerosis after a significant number of trials? Here’s what experts have to say
The FDA Is Banning Puff Bar E-Cigarettes From Being Sold in the United States
Puff Bar's e-cigarettes have been banned from being sold in the United States by the Food and Drug Administration.
Ancient Maya Civilization: Newly Discovered Artificial Plateau Challenges Traditional Archaeological Beliefs
Scientists have recently discovered new information about ancient Maya civilization breaking the traditional archaeological belief.
MORE IN ITECHPOST
At-Risk Mental Health for Students: Developing Resilience Among Students amid the Coronavirus Pandemic
At-Risk Mental Health for Students to help students struggling with their mental health, especially now amid the pandemic. It focuses more on developing students' resilience.
Tech Leaders and Health Authorities Join Forces, Launch New Initiative to Help Fight Pandemic and Future Epidemics
Two contact tracing apps have been successfully launched recently in Canada and Ireland. The open-source code underlying these apps has been contributed to a newly launched initiative to help other countries and U.S. states in the fight against the pandemic.
Fairy Tail Game Releases a Season Pass, a Week After It Was Launched
The anime RPG Fairy Tail from Koei Tecmo has just released a season pass that will release additional characters and content into the game, just a week after it was launched.